Thomas L Harrison - Net Worth and Insider Trading

Thomas L Harrison Net Worth

The estimated net worth of Thomas L Harrison is at least $163,524 dollars as of 2024-11-08. Thomas L Harrison is the Director of Advanced Flower Capital Inc and owns about 15,028 shares of Advanced Flower Capital Inc (AFCG) stock worth over $147,274. Thomas L Harrison is the Director of Zynerba Pharmaceuticals Inc and owns about 12,500 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $16,250. Thomas L Harrison is also the Director of Fifth Street Asset Management Inc and owns about 0 shares of Fifth Street Asset Management Inc (FSAM) stock worth over $0. Details can be seen in Thomas L Harrison's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas L Harrison has not made any transactions after 2021-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Thomas L Harrison

Thomas L Harrison Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas L Harrison owns 8 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , Fifth Street Asset Management Inc (FSAM) , and PLx Pharma Winddown Corp (PLXPQ) among others .

Click here to see the complete history of Thomas L Harrison’s form 4 insider trades.

Insider Ownership Summary of Thomas L Harrison

Ticker	Comapny	Transaction Date	Type of Owner
ZYNE	Zynerba Pharmaceuticals Inc	2016-05-25	director
FSAM	Fifth Street Asset Management Inc	2017-12-08	director
PLXPQ	PLx Pharma Winddown Corp	2014-03-12	director
		2013-12-03	director
		2012-05-17	director
		2004-06-29	Chrmn/CEO Divers. Agency Serv.
		2021-06-24	director
		2021-03-23	director

Thomas L Harrison Latest Holdings Summary

Thomas L Harrison currently owns a total of 3 stocks. Among these stocks, Thomas L Harrison owns 15,028 shares of Advanced Flower Capital Inc (AFCG) as of March 23, 2021, with a value of $147,274 and a weighting of 90.06%. Thomas L Harrison owns 12,500 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of August 10, 2015, with a value of $16,250 and a weighting of 9.94%. Thomas L Harrison also owns 0 shares of Fifth Street Asset Management Inc (FSAM) as of December 8, 2017, with a value of $0 and a weighting of 0%.

Latest Holdings of Thomas L Harrison

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AFCG	Advanced Flower Capital Inc	2021-03-23	15,028	9.80	147,274
ZYNE	Zynerba Pharmaceuticals Inc	2015-08-10	12,500	1.30	16,250
FSAM	Fifth Street Asset Management Inc	2017-12-08	0	0.01	0

Holding Weightings of Thomas L Harrison

Thomas L Harrison Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas L Harrison has made a total of 1 transactions in Advanced Flower Capital Inc (AFCG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Advanced Flower Capital Inc is the acquisition of 5,000 shares on March 23, 2021, which cost Thomas L Harrison around $95,000.

According to the SEC Form 4 filings, Thomas L Harrison has made a total of 0 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years. The most-recent trade in Zynerba Pharmaceuticals Inc is the acquisition of 12,500 shares on August 10, 2015, which cost Thomas L Harrison around $175,000.

According to the SEC Form 4 filings, Thomas L Harrison has made a total of 0 transactions in Fifth Street Asset Management Inc (FSAM) over the past 5 years. The most-recent trade in Fifth Street Asset Management Inc is the sale of 6,000 shares on December 8, 2017, which brought Thomas L Harrison around $24,300.

Insider Trading History of Thomas L Harrison

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas L Harrison Trading Performance

GuruFocus tracks the stock performance after each of Thomas L Harrison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas L Harrison is -32.24%. GuruFocus also compares Thomas L Harrison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas L Harrison within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas L Harrison's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas L Harrison

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-11.5
Relative Return to S&P 500(%)	-11.34

Thomas L Harrison Ownership Network

Ownership Network List of Thomas L Harrison

No Data

Ownership Network Relation of Thomas L Harrison

Thomas L Harrison Owned Company Details

What does Zynerba Pharmaceuticals Inc do?

Who are the key executives at Zynerba Pharmaceuticals Inc?

Thomas L Harrison is the director of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .

Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary

Over the past 18 months, Thomas L Harrison made no insider transaction in Zynerba Pharmaceuticals Inc (ZYNE). Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 17,830 shares made by Armando Anido , a net sale of 12,401 shares made by Terri B Sebree , and a net sale of 8,998 shares made by James E Fickenscher .

In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,835 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,835 shares.

Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zynerba Pharmaceuticals Inc Insider Transactions

No Available Data

What does Fifth Street Asset Management Inc do?

Who are the key executives at Fifth Street Asset Management Inc?

Thomas L Harrison is the director of Fifth Street Asset Management Inc. Other key executives at Fifth Street Asset Management Inc include 10 percent owner & President and CCO Bernard D Berman , director & 10 percent owner & CEO Leonard M Tannenbaum , and Co-President Patrick J Dalton .

Fifth Street Asset Management Inc (FSAM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Fifth Street Asset Management Inc (FSAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fifth Street Asset Management Inc (FSAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fifth Street Asset Management Inc (FSAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fifth Street Asset Management Inc Insider Transactions

No Available Data

What does PLx Pharma Winddown Corp do?

Who are the key executives at PLx Pharma Winddown Corp?

Thomas L Harrison is the director of PLx Pharma Winddown Corp. Other key executives at PLx Pharma Winddown Corp include director & Chief Executive Officer Natasha Giordano , Chief Financial Officer Rita M O'connor , and director & Executive Chairman Michael J Valentino .

PLx Pharma Winddown Corp (PLXPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PLx Pharma Winddown Corp (PLXPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PLx Pharma Winddown Corp (PLXPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PLx Pharma Winddown Corp (PLXPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PLx Pharma Winddown Corp Insider Transactions

No Available Data

What does RVUE Holdings Inc do?

Who are the key executives at RVUE Holdings Inc?

Thomas L Harrison is the director of RVUE Holdings Inc.

RVUE Holdings Inc (RVUE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RVUE Holdings Inc (RVUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RVUE Holdings Inc (RVUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RVUE Holdings Inc (RVUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

RVUE Holdings Inc Insider Transactions

No Available Data

What does Morgans Hotel Group Co do?

Who are the key executives at Morgans Hotel Group Co?

Thomas L Harrison is the director of Morgans Hotel Group Co. Other key executives at Morgans Hotel Group Co include See Remarks Meredith L Deutsch , other: Former Chief Executive Officer Michael Jonathan Gross , and director & 10 percent owner Ronald W Burkle .

Morgans Hotel Group Co (MHGC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Morgans Hotel Group Co (MHGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Morgans Hotel Group Co (MHGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Morgans Hotel Group Co (MHGC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Morgans Hotel Group Co Insider Transactions

No Available Data

What does Omnicom Group Inc do?

Who are the key executives at Omnicom Group Inc?

Thomas L Harrison is the Chrmn/CEO Divers. Agency Serv. of Omnicom Group Inc. Other key executives at Omnicom Group Inc include SVP & Chief Accounting Officer Andrew Castellaneta , Senior VP and Treasurer Rochelle M. Tarlowe , and CEO & Omnicom Digital Jonathan B. Nelson .

Omnicom Group Inc (OMC) Insider Trades Summary

Over the past 18 months, Thomas L Harrison made no insider transaction in Omnicom Group Inc (OMC). Other recent insider transactions involving Omnicom Group Inc (OMC) include a net sale of 2,502 shares made by Linda Johnson Rice , a net sale of 6,300 shares made by Rochelle M. Tarlowe , and a net sale of 7,300 shares made by Andrew Castellaneta .

In summary, during the past 3 months, insiders sold 7,000 shares of Omnicom Group Inc (OMC) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 41,102 shares of Omnicom Group Inc (OMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,102 shares.

Omnicom Group Inc (OMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Omnicom Group Inc Insider Transactions

No Available Data

What does Acurx Pharmaceuticals Inc do?

Who are the key executives at Acurx Pharmaceuticals Inc?

Thomas L Harrison is the director of Acurx Pharmaceuticals Inc. Other key executives at Acurx Pharmaceuticals Inc include director & 10 percent owner & President and CEO David P Luci , director & 10 percent owner Robert J Deluccia , and Chief Financial Officer Robert G. Shawah .

Acurx Pharmaceuticals Inc (ACXP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acurx Pharmaceuticals Inc (ACXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acurx Pharmaceuticals Inc (ACXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acurx Pharmaceuticals Inc (ACXP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acurx Pharmaceuticals Inc Insider Transactions

No Available Data

What does Advanced Flower Capital Inc do?

Who are the key executives at Advanced Flower Capital Inc?

Thomas L Harrison is the director of Advanced Flower Capital Inc. Other key executives at Advanced Flower Capital Inc include director & 10 percent owner & Chief Executive Officer Leonard M Tannenbaum , Managing Director Robyn Tannenbaum , and CFO and Treasurer Brandon Hetzel .

Advanced Flower Capital Inc (AFCG) Insider Trades Summary

Over the past 18 months, Thomas L Harrison made no insider transaction in Advanced Flower Capital Inc (AFCG). Other recent insider transactions involving Advanced Flower Capital Inc (AFCG) include a net purchase of 383,516 shares made by Leonard M Tannenbaum , and a net purchase of 243,372 shares made by Robyn Tannenbaum .

In summary, during the past 3 months, insiders sold 0 shares of Advanced Flower Capital Inc (AFCG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Advanced Flower Capital Inc (AFCG) were sold and 626,888 shares were bought by its insiders, resulting in a net purchase of 626,888 shares.

Advanced Flower Capital Inc (AFCG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Advanced Flower Capital Inc Insider Transactions

No Available Data

Thomas L Harrison Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas L Harrison. Currently GuruFocus does not have mailing address information for Thomas L Harrison.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.